Cubist Pharmaceuticals finds contaminant 2-mercaptobenzothiazole (MBT) in Cubicin infusion pumps

Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.

In this episode, our hosts examine the expanding role of incretin therapies in children and adolescents with obesity and type 2 diabetes.

GLP-1 adherence requires integrated care teams, administrative technology, and proactive clinical support to tackle complex challenges.

Pharmacist Stephanie Young Moss explains menopause symptoms, hormone therapy guidance, and how pharmacists can expand menopause care access.

Research shows that cost-plus pricing can lower drug costs dramatically, depending on where in the supply chain the markup is applied.

Medicaid and Part D low-income subsidy enrollment narrowed some gaps, but much of the disparity occurred within the same plans.

In part 1 of our midterm election FAQ series, AJ Barbarito, Esq, breaks down ongoing legal developments for pharmacists and what a change in Congressional control could mean for the profession.

A modeling study projects that a structured lifestyle program for adults with prediabetes would be cost-effective and likely cost saving.